Revolution rises 40% as pancreatic cancer drug doubles survival

BioSpace

In a difficult disease, Revolution Medicines achieved what the pancreatic cancer community has long desired: a significant improvement in survival.

pharminent April 13, 2026 (Last updated: April 13, 2026)

BioSpace

In a difficult disease, Revolution Medicines achieved what the pancreatic cancer community has long desired: a significant improvement in survival.

Related Stories